Methods for the Preparation and Manufacture of Polymeric Nanoparticles

Pharmaceutical Research

Volumn 26, Issue 5, 2009, Pages 1025-1058

  Vauthier, Christine ^a   Bouchemal, Kawthar ^a  

^a UNIV PARIS SUD   (France)

Author keywords

Gel; Nanocapsules; Nanospheres; Polyelectrolyte complex; Polymerization; Precipitation; Purification; Scale up

Indexed keywords

ALBUMIN; ALGINIC ACID; ALPHA TOCOPHEROL; BOVINE SERUM ALBUMIN; CHITOSAN; CROMOGLYCATE DISODIUM; CYCLOSPORIN A; DEXAMETHASONE; DEXTRAN; DOXORUBICIN; GELATIN; INDOMETACIN; INSULIN; KETOPROFEN; LYSOZYME; NANOCAPSULE; NANOPARTICLE; NANOSPHERE; PACLITAXEL; POLOXAMER; POLYCAPROLACTONE; POLYELECTROLYTE; POLYGLACTIN; POLYMER; POLYSORBATE 20; POLYSORBATE 80; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN; VITAMIN K GROUP;

CHEMICAL LABELING; FREEZE DRYING; IN VITRO STUDY; IN VIVO STUDY; NANOFABRICATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PRODUCTIVITY; PURIFICATION; REVIEW; SCALE UP; SPRAY DRYING; SYNTHESIS;

EID: 63949086707     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9800-3     Document Type: Review

References (270)

1. J. C. Allémann Leroux R. Gurny 1998 Polymeric nano-and microparticles for the oral delivery of peptides and peptidomimetics Adv. Drug Deliv. Rev. 34 2-3 171 189
2. P. Couvreur C. Vauthier 2006 Nanotechnology: intelligent design to treat complex disease Pharm. Res. 23 1417 1450
3. R. Juliano M. R. Alam V. Dixit H. Kang 2008 Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides Nucleic Acids Res. 36 12 4158 4171
4. C. Pinto-Reis R. J. Neufeld A. J. Ribeiro F. Veiga 2006 Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles Nanomedicine 2 8 21
5. A. F. Soares R. A. de Carvalho F. Veiga 2007 Oral administration of peptides and proteins: nanoparticles and cyclodextrins as biocompatible delivery systems Nanomedicine 2 2 183 202
6. C. Vauthier D. Labarre 2008 Modular biomimetic drug delivery systems J. Drug Deliv. Sci. Technol. 18 1 59 68
7. H. de Martimprey, C. Vauthier, C. Malvy, and P. Couvreur. Polymer nanocarriers for the delivery of small fragments of nucleic acids: Oligonucleotides and siRNA. Eur. J. Pharm. Biopharm., in press (2008)
8. C. Pichot, and J. C. Daniel (eds.), Latex Synthétiques : Elaboration-Propriétés-Applications, Lavoisier, Paris, France, 2006.
9. W. A. Braunecker K. Matyjaszewski 2007 Controlled/living radical polymerization: features, developments and perspectives Prog. Polymer. Sci. 33 93 146
10. C. Vauthier-Holtzscherer S. Benabbou G. Spenlehauer M. Veillard P. Couvreur 1991 Methodology for the preparation of ultradispersed polymer systems STP Pharma Sci. 1 109 116
11. E. Allémann R. Gurny E. Doelker 1993 Drug loaded nanoparticles. Preparation, methods and drug targeting issues Eur. J. Pharm. Biopharm. 39 173 191
12. D. Quintanar-Guerrero E. Allémann H. Fessi E. Doelker 1998 Preparation techniques and mechanism of formation of biodegradable nanoparticles from preformed polymers Drug Dev. Ind. Pharm. 24 1113 1128
13. F. De Jaeghere, E. Doelker, and R. Gurny. Nanoparticles. In E. Mathiowitz (ed.), The Encyclopedia of Controlled Drug Delivery, Wiley, New York, 1999, pp. 641-664.
14. P. Couvreur G. Barratt E. Fattal P. Legrand C. Vauthier 2002 Nanocapsule technology: a review Crit. Rev. Ther. Drug. Carrier Syst. 19 2 99 134
15. C. Vauthier, E. Fattal, and D. Labarre. From polymer chemistry and physicochemistry to nanoparticular drug carrier design and applications. In M. J. Yaszemski, D. J. Trantolo, K. U. Lewamdrowski, V. Hasirci, D. E. Altobelli, and D. L. Wise (eds.), Biomaterial Handbook-Advanced Applications of Basic Sciences and Bioengineering, Marcel Dekker, New York, 2004, pp. 563-598.
16. D. Moinard-Chécot Y. Chevalier S. Briançon H. Fessi S. Guinebretière 2006 Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process J. Nanosci. Nanotechnol. 6 9-10 2664 2681
17. C. Vauthier. Généralités sur les techniques d'émulsification et d'obtention de dispersions de particules polymère : avantages et inconvénients. In C. Pichot et, and J. C. Daniel (eds.), Latex Synthétiques : Elaboration-Propriétés- Applications, Lavoisier, Paris, 2006, pp. 291-317.
18. N. Al Khoury-Fallouh L. Roblot-Treupel H. Fessi J. P. Devissaguet F. Puisieux 1986 Development of a new process for the manufacture of poly(isobutylcyanoacrylate) nanocapsules Int. J. Pharm. 28 125 136
19. H. Vranckx M. Demoustier M. Deleers 1996 A new nanocapsule formulation with hydrophilic core: Application to the oral administration of salmon calcitonin in rats J. Pharm. Pharmacol. 42 345 347
20. G. Lambert E. Fattal H. Pinto-Alphandary A. Gulik P. Couvreur 2000 Polyisobutylcyanoacrylate nanocapsules containing an aqueous core as a novel colloidal carrier for the delivery of oligonucleotides Pharm. Res. 17 6 707 714
21. M. Wohlgemuth W. Mächtle C. Mayer 2000 Improved preparation and physical studes of polybutylcyanoacrylate nanocapsules J. Microencapsulation 17 437 448
22. C. Mayer 2005 Nanocapsules as drug delivery systems Int. J. Artif. Organs 28 11 1163 1171
23. H. Hillaireau T. Le Doan M. Appel P. Couvreur 2006 Hybrid polymer nanocapsules enhance in vitro delivery of azidothymidine-triphosphate to macrophages J. Control. Release 116 346 352
24. S. Watnasirichaikul T. Rades I. G. Tucker N. M. Davies 2002 Effects of formulation variables on characteristics of poly(ethylcyanoacrylate) nanocapsules prepared from w/o microemulsions Int. J. Pharm. 235 237 246
25. K. Bouchemal S. Briançon E. Perrier H. Fessi I. Bonnet N. Zydowicz 2004 Synthesis and characterization of polyurethane and poly (ether urethane) nanocapsules using a new technique of interfacial polycondensation combined to spontaneous emulsification Int. J. Pharm. 269 1 89 100
26. K. Bouchemal S. Briançon H. Fessi Y. Chevalier I. Bonnet E. Perrier 2006 Simultaneous emulsification and interfacial polycondensation for the preparation of colloidal suspension of nanocapsules Mater. Sci. Eng. C. 26 472 480
27. N. Ammoury H. Fessi J. P. Devissaguet F. Puisieux S. Benita 1990 In vitro release kinetic pattern of indomethacin from poly(D,L-lactide) nanocapsules J. Pharm. Sci. 79 9 763 767
28. D. Quintanar-Guerrero É. Allémann É. Doelker H. Fessi 1998 Preparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion technique Pharm. Res. 15 1056 1062
29. M. F. Zambaux F. Bonneaux R. Gref P. Maincent E. Dellacherie M. J. Alonso P. Labrude C. Vigneron 1998 Influence of experimental parameters on the characteristics of poly(lactic acid) nanoparticles prepared by a double emulsion method J. Control. Release 50 1-3 31 40
30. D. Moinard-Chécot Y. Chevalier S. Briançon L. Beney H. Fessi 2008 Mechanism of nanocapsules formation by the emulsion-diffusion process J. Colloid Interface Sci. 317 458 468
31. M. Skiba. Developpement pharmacotechnique et biopharmaceutique de nouveaux vecteurs colloidaux : nanoparticles à base de cyclodextrines modifiées. Ph.D. Université de Paris Sud-11, décembre 1994.
32. C. Vauthier, and P. Couvreur. Development of nanoparticles made of polysaccharides as novel drug carrier systems. In D. L. Wise (ed.), Handbook of Pharmaceutical Controlled Release Technology, Marcel Dekker, New York, 2000, pp. 413-429.
33. E. Martinez-Barbosa. Synthèse de dérivés de poly(L-glutamate de γ-benzyle). Préparation et caracté risation de nanoparticules multifonctionnelles. Ph. D. Université Paris Sud-11. 2006.
34. N. Toub C. Malvy E. Fattal P. Couvreur 2006 Innovative nanotechnologies for the delivery of oligonucleotides and siRNA Biomed. Pharmacother. 60 9 607 620
35. C. Perez A. Sanchez D. Putnam D. Ting R. Langer M. J. Alonso 2001 Poly(lactic acid)-poly(ethylene glycol) nanoparticles as new carriers for the delivery of plasmid DNA J. Control. Release 75 211 224
36. C. G. Oster M. Wittmar F. Unger L. Barbu-Tudoran A. K. Schaper T. Kissel 2004 Design of amine-modified graft polyesters for effective gene delivery using DNA-loaded nanoparticles Pharm. Res. 21 6 927 931
37. V. Vogel D. Lochmann J. Weyermann G. Mayer C. Tziatzios J. A. van den Broek W. Haase D. Wouters U. S. Schubert J. Kreuter A. Zimmer D. Schubert 2005 Oligonucleotide-protamine-albumin nanoparticles: preparation, physical properties and intracellular distribution J. Control. Release 103 1, 2 99 111
38. N. Nafee S. Taetz M. Schneider U. F. Schaefer C. M. Lehr 2007 Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides Nanomedicine 3 3 173 183
39. H. Hillaireau T. Le Doan H. Chacun J. Janin P. Couvreur 2007 Encapsulation of mono-and oligo-nucleotides into aqueous-core nanocapsules in presence of various water-soluble polymers Int. J. Pharm. 331 2 148 152
40. C. Chavany T. Le Doan P. Couvreur F. Puisieux C. Hélèna 1992 Polyalkylcyanoacrylate nanoparticles as polymeric carriers for antisense oligonucleotides Pharm. Res. 9 4 441 449
41. P. Zobel M. Junghans V. Maienschein D. Werner M. Gilbert H. Zimmermann C. Noe J. Kreuter A. Zimmer 2000 Enhanced antisense efficacy of oligonucleotides adsorbed to monomethylaminoethylmethacrylate methylmethacrylate copolymer nanoparticles Eur. J. Pharm. Biopharm. 49 3 203 210
42. H. de Martimprey J. R. Bertrand A. Fusco M. Santoro P. Couvreur C. Vauthier C. Malvy 2008 siRNA nanoformulation against the ret/PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma Nucleic Acids Res. 36 1 e2
43. M. Okada 2002 Chemical synthesis of biodegradable polymers Prog. Polym. Sci. 27 87 133
44. L. Y Qiu Y. H. Bae 2006 Polymer architecture and drug delivery Pharm. Res. 23 1 1 30
45. S. Slomkovski 2006 Biodegradable nano-and microparticles as carriers of bioactive compounds Acta Pol. Pharm. 63 5 351 358
46. L. S. Nair C. T. Laurencin 2007 Biodegradable polymers as biomaterials Prog. Polym. Sci. 32 762 789
47. V. P. Torchilin V. S. Trubetskoy 1995 Which polymers can make nanoparticulate drug carriers long-circulating? Adv. Drug Deliv. Rev. 16 141 155
48. K. Avgoustakis 2004 Pegylated poly(lactide) and poly(lactide-co- glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Deliv. 1 4 321 333
49. V. C. Mosqueira P. Legrand J. L. Morgat M. Vert E. Mysiakine R. Gref J. P. Devissaguet G. Barratt 2001 Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density Pharm. Res. 18 10 1411 1419
50. C. Lemarchand P. Couvreur C. Vauthier D. Costantini R. Gref 2003 Study of emulsion stabilization by graft copolymers using the optical analyzer Turbiscan Int. J. Pharm. 254 1 77 82
51. C. Chauvierre D. Labarre P. Couvreur C. Vauthier 2003 Novel polysaccharide-decorated poly(isobutyl cyanoacrylate) nanoparticles Pharm. Res. 20 1786 1793
52. C. Chauvierre D. Labarre P. Couvreur C. Vauthier 2004 A new approach for the characterization of insoluble amphiphilic copolymers based on their emulsifying properties Colloid Polym. Sci. 282 1097 1104
53. N. Anton J. P. Benoit P. Saulnier 2008 Design and production of nanoparticles formulated from nano-emulsion templates-A review J. Control. Release 128 185 199
54. M. Stork R. L. Tousain J. A. Wieringa O. H. Bosgra 2003 A MILP approach to the optimization of the operation procedure of a fed-batch emulsification process in a stirred vessel Comp. Chem. Eng. 27 1681 1691
55. C. Mabille F. Leal-Calderon J. Bibette V. Schmitt 2003 Monodisperse fragmentation in emulsions: Mechanisms and kinetics Europhys. Lett. 61 5 708 714
56. C. Charcosset H. Fessi 2005 Preparation of nanoparticles with a membrane contactor J. Membrane Sci. 266 115 120
57. S. Freitas H. P. Merkle B. Gander 2005 Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology J. Control. Release 102 2 313 332
58. I. Kobayashi S. Mukataka M. Nakajima 2005 Effects of type and physical properties of oil phase on oil-in-water emulsion droplet formation in straight-through microchannel emulsification, experimental and CFD studies Langmuir 21 13 5722 2730
59. M. J. Geerken R. G. H. Lammertink M. Wessling 2007 Interfacial aspects of water drop formation at micro-engineered orifices J. Colloid Interface Sci. 312 2 460 446
60. C. Charcosset A. El-Harati H. Fessi 2005 Preparation of solid lipid nanoparticles using a membrane contactor J. Control. Release 108 112 120
61. I. Limayem Blouza C. Charcosset S. Sfar H. Fessi 2006 Preparation and characterization of spironolactone-loaded nanocapsules for paediatric use Int. J. Pharm. 325 124 131
62. N. Sheibat-Othman T. Burne C. Charcosset H. Fessi 2008 Preparation of pH-sensitive particles by membrane contactor Colloid Surf. A 315 13 22
63. S. Desgouilles C. Vauthier D. Bazile J. Vacus J.-L. Grossiord M. Veillard P. Couvreur 2003 The design of nanoparticles obtained by solvent evaporation: a comprehensive study Langmuir 19 22 9504 9510
64. S. A. Vitale J. L. Katz 2003 Liquid droplet dispersions formed by homogeneous liquid-liquid nucleation: "The ouzo effect" Langmuir 19 10 4105 4110
65. K. Bouchemal S. Briançon E. Perrier H. Fessi 2004 Nano-emulsion formulation using spontaneous emulsification: Solvent, oil and surfactant optimization Int. J. Pharm. 280 1-2 241 251
66. F. Ganachaud J. Katz 2005 Nanoparticles and nanocapsules created using the ouzo effect: spontaneous emulsification as an alternative to ultrasonic and high-shear devices Chem. Phys. Chem. 6 209 216
67. J. W. Nah, T. R. Jung, Y. L. Jeong, M. K. Jang. Biodegradable nanoparticles of poly(DL-lactide-co-glycolide) encapsulating ciprofloxacin HCl having an extended-release property and manufacturing method thereof. World Patent 054042 (2008).
68. C. K. Weiss U. Ziener K. Landfester 2007 A route to nonfunctionalized and functionalized poly(n-butylcyanoacrylate) nanoparticles: preparation in miniemulsion Macromolecules 40 4 928 938
69. K. Landfester 2001 Polyreactions in miniemulsions Macromol. Rapid Comm. 22 896 936
70. J. Qiu B. Charleux K. Matyjaszewski 2001 Controlled/living radical polymerization in aqueous media: homogeneous and heterogeneous systems Prog. Polym. Sci. 26 2083 2134
71. R. Gref Y. Minamitake M. T. Peracchia V. Trubetskoy V. Torchilin R. Langer 1994 Biodegradable long-circulating polymeric nanospheres Science 263 1600 1603
72. D. Bazile C. Prud'homme M. T. Bassoulet M. Marlard G. Spenlehauer M. Veillard 1995 Stealth Me-PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system J. Pharm. Sci. 84 493 498
73. C. Lemarchand P. Couvreur M. Besnard D. Costantini R. Gref 2003 Novel polyester-polysaccharide nanoparticles Pharm. Res. 20 8 1284 1292
74. R. Gurny N. A. Peppas D. D. Harrington G. S. Banker 1981 Development of biodegradable and injectable lattices for controlled release potent drugs Drug. Dev. Ind. Pharm. 7 1 25
75. E. Allémann R. Gurny E. Doelker 1992 Preparation of aqueous polymeric nanodispersions by a reversible salting-out process: influence of process parameters on particle size Int. J. Pharm. 87 1-3 247 253
76. W. Y. Dong M. Körber V. López Esguerra R. Bodmeier 2006 Stability of poly(D,L-lactide-co-glycolide) and leuprolide acetate in in-situ forming drug delivery systems J. Control. Release 115 2 158 167
77. F. Delie M. Berton E. Allémann R. Gurny 2001 Comparison of two methods of encapsulation of an oligonucleotide into Poly(D,L-Lactic Acid) particles Int. J. Pharm. 214 25 30
78. U. Bilati E. Allémann E. Doelker 2005 Poly(D,L-lactide-co- glycolide) protein-loaded nanoparticles prepared by the double emulsion method-processing and formulation issues for enhanced entrapment efficiency J. Microencapsul. 22 2 205 214
79. J. W. Vanderhoff, M. S. El Aasser, and J. Ugelstad. Polymer emulsification process. US Patent 4,177,177 (1979).
80. D. Quintanar-Guerrero E. Allémann H. Fessi E. Doelker 1999 Pseudolatex preparation using a novel emulsion-diffusion process involving direct displacement of partially water-miscible solvents by distillation Int. J. Pharm. 188 2 155 164
81. R. C. Mundargi V. R. Babu V. Rangaswamy P. Patel T. M. Aminabhavi 2008 Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives J. Control. Release 125 3 193 209
82. I. Brigger P. Chaminade D. Desmaële M. T. Peracchia J. d'Angelo R. Gurny M. Renoir P. Couvreur 2000 Near infrared with principal component analysis as a novel analytical approach for nanoparticle technology Pharm. Res. 17 9 1124 1132
83. J. C. Leroux E. Allemann E. Doelker R. Gurny 1995 New approach for the preparation of nanoparticles by an emulsification-diffusion method Eur. J. Pharm. Biopharm. 41 1 14 18
84. D. Quintanar-Guerrero E. Allémann E. Doelker H. Fessi 1997 A mechanistic study of the formation of polymer nanoparticles by the emulsification-diffusion technique Colloid Polym. Sci. 275 640 647
85. D. Quintanar-Guerrero É. Allémann H. Fessi E. Doelker 1996 Influence of stabilizing agents and preparative variables on the formation of poly(-lactic acid) nanoparticles by an emulsification-diffusion technique Int. J. Pharm. 143 133 141
86. S. Guinebretière. Nanocapsules par émulsion-diffusion de solvant: obtention, caractérisation et mécanisme de formation. Ph.D. Université Claude Bernard Lyon 1 (2001).
87. D. Quintanar-Guerrero D. Tamayo-Esquivel A. Ganem-Quintanar E. Allémann E. Doelker 2005 Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres Eur. J. Pharm. Sci. 26 211 218
88. M. Trotta F. Debernardi O. Caputo 2003 Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique Int. J. Pharm. 257 153 160
89. L. Battaglia M. Trotta M. Gallarate M. E. Carlotti G. P. Zara A. Bargoni 2007 Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: Development and influence on insulin stability J. Microencapsul. 24 672 684
90. D. Quintanar-Guerrero A. Ganem-Quintanar E. Allemann H. Fessi E. Doelker 1998 Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique J. Microencapsul. 15 107 119
91. F. F. De Jaeghere E. Allémann F. Kubel B. Galli R. Cozens E. Doelker R. Gurny 2000 Oral bioavailability of a poorly water soluble HIV-1 protease inhibitor incorporated into pH-sensitive particles: effect of the particle size and nutritional state J. Control. Release 68 2 291 298
92. M. Berton E. Allemann C. A. Stein R. Gurny 1999 Highly loaded nanoparticulate carrier using an hydrophobic antisense oligonucleotide complex Eur. J. Pharm. Sci. 9 2 163 170
93. Y. N. Konan R. Cerny J. Favet M. Berton R. Gurny E. Allémann 2003 Preparation and characterization of sterile sub-200 nm meso-tetra(4- hydroxylphenyl)porphyrin-loaded nanoparticles for photodynamic therapy Eur. J. Pharm. Biopharm. 55 115 124
94. H. S. Yoo J. E. Oh K. H. Lee T. G. Park 1996 Biodegradable nanoparticles containing PLGA conjugate for sustained release Pharm. Res. 16 1114 1118
95. S. Guinebretière S. Briancon H. Fessi V. S. Teodorescu M. G. Blanchin 2002 Nanocapsules of biodegradable polymers: preparation and characterization by direct high resolution electron microscopy Mater. Sci. Eng. C. 21 137 142
96. D. Quintanar, H. Fessi, É. Doelker, and E. Allémann, Procédé de préparation de nanocapsules de type vésiculaire. World Patent 004766 (1999).
97. H. Ibrahim C. Bindschaedler E. Doelker P. Buri R. Gurny 1992 Aqueous nanodispersions prepared by a salting-out process Int. J. Pharm. 87 239 246
98. E. Allémann J. C. Leroux R. Gurny E. Doelker 1993 In vitro extended-release properties of drug-loaded poly(DL-lactic acid) nanoparticles produced by a salting-out procedure Pharm. Res. 10 1732 1737
99. E. Allémann E. Doelker R. Gurny 1993 Drug loaded poly(lactic acid) nanoparticles produced by a reversible salting-out process: purification of an injectable dosage form Eur. J. Pharm. Biopharm. 39 13 18
100. N. Wang X. S. Wu 1997 Preparation and characterization of agarose hydrogel nanoparticles for protein and peptide drug delivery Pharm. Dev. Technol. 2 135 142
101. H. Tokumitsu, H. Ichikawa, Y. Fukumori, J. Hiratsuka, Y. Sakurai, and T. Kobayashi. Preparation of gadopentenate-loaded nanoparticles for gadolinium neutron capture therapy of cancer using a novel emulsion droplet coalescence technique. Proc. 2nd world meeting APGI/APV, Paris, France, 25-28 Mai 1998, pp. 641-642 (1998).
102. C. Pinto-Reis A. J. Ribeiro F. Veiga R. J. Neufeld C. Damgé 2008 Polyelectrolyte biomaterial interactions provide nanoparticulate carrier for oral insulin delivery Drug. Deliv. 15 2 127 139
103. P. Couvreur B. Kante M. Roland P. Guiot P. Baudhuin P. Speiser 1979 Poly(cyanoacrylate) nanoparticles as potential lysosomotropic carriers: preparation, morphological and sorptive properties J. Pharm. Pharmacol. 31 331 332
104. C. Chauvierre D. Labarre P. Couvreur C. Vauthier 2003 A radical emulsion polymerization of alkylcyanoacrylates initiated by the redox system dextran-cerium IV in acidic aqueous conditions Macromolecules 36 6018 6027
105. I. Bertholon S. Lesieur D. Labarre M. Besnard C. Vauthier 2006 Characterization of dextran-poly(isobutylcyanoacrylate) copolymers obtained by redox radical and anionic emulsion polymerization Macromolecules 39 3559 3567
106. I. Bertholon C. Vauthier D. Labarre 2006 Complement Activation by core-shell poly(isobutylcyanoacrylate)-polysaccharide nanoparticles: influences of surface morphology, length and type of polysaccharide Pharm. Res. 23 1313 1323
107. M. R. Gasco M. Trotta 1986 Nanoparticles from microemulsions Int. J. Pharm. 29 267 268
108. S. Watnasirichaikul M. N. Davies R. Rades I. G. Tucker 2000 Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions Pharm. Res. 17 684 689
109. K. Bouchemal F. Couenne S. Briançon H. Fessi M. Tayakout 2006 Stability studies on colloidal suspensions of polyurethane nanocapsules J. Nanosci. Nanotechno. 6 3187 3192
110. C. Vauthier D. Labarre G. Ponchel 2007 Design aspects of poly(alkylcyanoacrylate) nanoparticles for drug delivery J. Drug. Targeting 15 641 663
111. C. Pinto-Reis R. J. Neufeld A. J. Ribeiro F. Veiga 2006 Nanoencapsulation II. Biomedical applications and current status of peptide and protein nanoparticulate delivery systems Nanomedicine 2 2 53 65
112. G. E. Ghanem C. Joubran R. Arnould F. Lejeune J. Fruhling 1993 Labelled polycyanoacrylate nanoparticles for human in vivo use Appl. Radiat. Isotopes 44 9 1219 1224
113. R. K. Kulkarni D. E. Bartak F. Leonard 1971 Initiation of polymerization of alkyl 2-cyanoacrylates in aqueous solutions of glycine and its derivatives J. Polym. Sci. A. Polym. Chem. 9 10 2977 2981
114. S. J. Douglas L. Illum S. S. Davis 1985 Particle size and size distribution of poly(butyl 2-cyanoacrylate) nanoparticles. II. Influence of stabilizers J. Colloid Interface Sci. 103 154 163
115. M. T. Peracchia C. Vauthier M. Popa F. Puisieux P. Couvreur 1997 An investigation on the formation of sterically stabilized PEG-PIBCA nanoparticles by chemical grafting of PEG during the polymerization of isobutylcyanoacrylate STP Pharma Sci. 7 514 521
116. C. Chauvierre D. Labarre P. Couvreur C. Vauthier 2003 Plug-in spectrometry with optical fibers as a novel analytical tool for nanoparticles technology: application to the investigation of the emulsion polymerization of the alkylcyanoacrylate J. Nanopart. Res. 5 365 371
117. S. C. Yang H. X. Ge Y. Hu X. Q. Jiang C. Z. Yang 2000 Formation of positively charged poly(butyl cyanoacrylate) nanoparticles stabilized by chitosan Colloid Polym. Sci. 278 285 292
118. D. Labarre C. Vauthier C. Chauvierre B. Petri R. Müller M. M. Chehimi 2005 Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush Biomaterials 26 24 5075 5084
119. I. Bravo-Osuna G. Ponchel C. Vauthier 2007 Tuning of shell and core characteristics of chitosan-decorated acrylic nanoparticles Eur. J. Pharm. Sci. 30 143 154
120. I. Bravo Osuna, C. Vauthier, and G. Ponchel. Core-shell polymer nanoparticle formulations for the oral administration of peptides and proteins. In A. O. Hartmann, and L. K. Newmann (eds.), Drugs: Approval, Evaluation, Delivery and Control, Novapublishers, New York, 2008, pp. 35-71.
121. M. T. Peracchia C. Vauthier C. Passirani P. Couvreur D. Labarre 1997 Complement consumption by poly(ethylene glycol) in different configurations chemically coupled to polyisobutylcyanoacrylate nanoparticles Life Sci. 61 749 761
122. C. Passirani G. Barratt J. P. Devissaguet D. Labarre 1998 Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) Pharm. Res. 15 7 1046 1050
123. I. Bravo-Osuna C. Vauthier A. Farabollini G. F. Palmieri G. Ponchel 2007 Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles Biomaterials 28 13 2233 2243
124. I. Bravo-Osuna C. Vauthier H. Chacun G. Ponchel 2008 Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate) core-shell nanoparticles Eur. J. Pharm. Biopharm. 69 436 444
125. M. Aboubakar F. Puisieux P. Couvreur M. Deyme C. Vauthier 1999 Study of the mechanism of insulin encapsulation in poly(isobutylcyanoacrylate) nanocapsules obtained by interfacial polymerization J. Biomed. Mater. Res. 47 568 576
126. M. Gallardo G. Couarraze B. Denizot L. Treupel P. Couvreur F. Puisieux 1993 Study of the mechanism of formation of nanoparticles and nanocapsules of poly(isobutyl-2-cyanoacrylate) Int. J. Pharm. 100 55 64
127. G. Puglisi M. Fresta G. Giammona C. A. Ventura 1995 Influence of the preparation conditions on poly(ethylcyanoacrylate) nanocapsule formation Int. J. Pharm. 125 283 287
128. N. Altinbas C. Fehmer A. Terheiden A. Shukla H. Rehage C. Mayer 2006 Alkylcyanoacrylate nanocapsules prepared from mini-emulsions: a comparison with the conventional approach J. Microencapsul. 23 5 567 581
129. C. Y. Huang C. M. Chen Y. D. Lee 2007 Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion Int. J. Pharm. 338 1-2 267 275
130. K. Krauel N. M. Davies S. Hook T. Rades 2005 Using different structure types of microemulsions for the preparation of poly(alkylcyanoacrylate) nanoparticles by interfacial polymerization J. Control. Release 106 76 87
131. I. Montasser, H Fessi, S. Briançon, and J. Lieto. Procédé de préparation de particules colloïdales sous forme de nanocapsules. World Patent 0168235 (2001).
132. I. Montasser S. I. Briançon H. Fessi 2007 The effect of monomers on the formulation of polymeric nanocapsules based on polyureas and polyamides Int. J. Pharm. 335 1-2 176 179
133. K. Bouchemal F. Couenne S. Briançon H. Fessi M. Tayakout 2006 Polyamides nanocapsules: modelling and wall thickness estimation AIChE J. 52 6 1 10
134. H. Fessi F. Puisieux J.-P. Devissaguet N. Ammoury S. Benita 1989 Nanocapsule formation by interfacial deposition following solvent displacement Int. J. Pharm. 55 R1 R4
135. R. A. Jain 2000 The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices Biomaterials 21 2475 2490
136. T. Delair. Colloidal particles: elaboration from preformed polymers. In A. Elaissari (ed.), Colloidal Biomolecules, Biomaterials and Biomedical Applications, Marcel Dekker, New York, 2004, pp. 329-347.
137. O. Thioune H. Fessi J. P. Devissaguet F. Puisieux 1997 Preparation of pseudolatex by nanoprecipitation: Influence of the solvent nature on intrinsic viscosity and interaction constant Int. J. Pharm. 146 233 238
138. P. Legrand S. Lesieur A. Bochot R. Gref W. Raatjes G. Barratt C. Vauthier 2007 Influence of polymer behaviour in organic solution on the production of polylactide nanoparticles by nanoprecipitation Int. J. Pharm. 344 33 43
139. H. Murakami M. Kobayashi H. Takeuchi Y. Kawashima 1999 Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method Int. J. Pharm. 187 2 143 152
140. M. T. Peracchia C. Vauthier D. Desmaël A. Gulik J. C. Dedieu M. Demoy J. D'Angelo P. Couvreur 1998 Pegylated nanoparticles from a novel methoxypolyethyleneglycol cyanoacrylate-hexadecyl cyanoacrylate amphiphilic copolymer Pharm. Res. 15 550 556
141. C. Duclairoir E. Nakache H. Marchais A. M. Orecchioni 1998 Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent Colloid Polym. Sci. 276 321 327
142. M. Skiba D. Wouessidjewe F. Puisieux D. Duchène A. Gulik 1996 Characterization of amphiphilic fl-cyclodextrin nanospheres Int. J. Pharm. 142 121 124
143. H. Lannibois-Drean. Des molécules hydrophobes dans l'eau: fabrication de nanoparticles par precipitation. Ph.D. Université Pierre et Marie Curie, Paris, France (1995).
144. H. Lannibois A. Hasmy R. Botet O. Aguerre Chariol B. Cabane 1997 Surfactant limited aggregation of hydrophobic molecules in water J. Phys. II 7 319 342
145. T. Niwa T. Takeuchi T. Hino N. Kunou Y. Kawashima 1993 Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with d,llactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior J. Control. Release 25 89 98
146. H. Murakami M. Kobayashi H. Takeuchi Y. Kawashima 2000 Further application of a modified spontaneous emulsification solvent diffusion method to various types of PLGA and PLA polymers for preparation of nanoparticles Powder Technol. 107 137 143
147. L. Peltonen J. Anitta S. Hyvönen M. Kajalainen J. Hirvonen 2004 Improved entrapment efficiency of hydrophilic drug substance during nanoprecipitation of poly(l)lactide nanoparticles AAPS PharmSciTech 5 1 1 6
148. I. Limayem C. Charcosset H. Fessi 2004 Purification of nanoparticle suspensions by a concentration/diafiltration process Sep. Purif. Technol. 38 1 9
149. F. Némati C. Dubernet H. Fessi A. C. Verdière M. F. Poupon F. Puisieux P. Couvreur 1996 Reversion of multidrug resistance using nanoparticles in vitro: influence of the nature of the polymer Int. J. Pharm. 138 237 246
150. U. Bilati E. Allémann E. Doelker 2005 Nanoprecipitation Versus Emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues AAPS PharmSciTech. 6 4 E594 E604
151. J. M. Barichello M. Morishita K. Takayama T. Nagai 1999 Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method Drug. Dev. Ind. Pharm. 25 471 476
152. J. Molpeceres M. Guzman M. R. Aberturas M. Chacon L. Berges 1996 Application of central composite design to the preparation of polycaprolactone nanoparticles by solvent displacement J. Pharm. Sci. 85 206 13
153. Y. Zhang R.-X. Zhuo 2005 Synthesis and in vitro drug release behavior of amphiphilic triblock copolymer nanoparticles based on poly (ethylene glycol) and polycaprolactone Biomaterials 26 6736 6742
154. P. Arbós M. A. Campanero M. A. Arangoa M. J. Renedo J. M. Irache 2003 Influence of the surface characteristics of PVM/MA nanoparticles on their bioadhesive properties J. Control Release 89 19 30
155. M. Skiba C. Morvan D. Duchene F. Puisieux D. Wouessidjewe 1995 Evaluation of gastrointestinal behaviour in the rat of amphiphilic β-cyclodextrin nanocapsules, loaded with indomethacin Int. J. Pharm. 126 275 279
156. E. Lemos-Senna D. Wouessidjewe S. Lesieur F. Puisieux G. Couarraze D. Duchêne 1998 Evaluation of the hydrophobic drug loading characteristics in nanoprecipitated amphiphilic cyclodextrin nanospheres Pharm. Dev. Technol. 3 1 85 94
157. E. Lemos-Senna D. Wouessidjewe S. Lesieur D. Duchêne 1998 Preparation of amphiphilic cyclodextrin nanospheres using the emulsification solvent evaporation method. Influence of the surfactant on preparation and hydrophobic drug loading Int. J. Pharm. 170 119 128
158. K. A. Howard J. Kjems 2007 Polycation-based nanoparticle delivery for improved RNA interference therapeutics Expert. Opin. Biol. Ther. 7 12 1811 1822
159. M. Rajaonarivony C. Vauthier G. Couarraze F. Puisieux P. Couvreur 1993 Development of a new drug carrier made from alginate J. Pharm. Sci. 82 912 918
160. C. Schatz A. Domard C. Viton C. Pichot T. Delair 2004 Versatile and efficient formation of colloids of biopolymer-based polyelectrolyte complexes Biomacromolecules 5 5 1882 1892
161. A. Drogoz L. David C. Rochas A. Domard T. Delair 2007 Polyelectrolyte complexes from polysaccharides: formation and stoichiometry monitoring Langmuir 23 22 10950 10958
162. A. Drogoz S. Munier B. Verrier L. David A. Domard T. Delair 2008 Towards biocompatible vaccine delivery systems: interactions of colloidal PECs based on polysaccharides with HIV-1 p24 antigen Biomacromolecules 9 2 583 591
163. R. Gref C. Amiel K. Molinard S. Daoud-Mahammed B. Sébille B. Gillet c J-C. Beloeil C. Ringard V. Rosilio J. Poupaert P. Couvreur 2006 New
164. S. Daoud-Mahammed C. Ringard-Lefebvre N. Razzouq V. Rosilio B. Gillet P. Couvreur C. Amiel R. Gref 2007 Spontaneous association of hydrophobized dextran and poly-β-cyclodextrin into nanoassemblies. Formation and interaction with a hydrophobic drug J. Colloid Interface Sci. 307 1 83 93
165. S. De D. Robinson 2003 Polymer relationships during preparation of chitosan-alginate and poly-l-lysine-alginate nanospheres J. Control. Release 89 1 101 12
166. K. L. Douglas M. Tabrizian 2005 Effect of experimental parameters on the formation of alginate-chitosan nanoparticles and evaluation of their potential application as DNA carrier J. Biomater. Sci. Polym. E 16 1 43 56
167. B. Sarmento A. J. Ribeiro F. Veiga D. C. Ferreira R. J. Neufeld 2007 Insulin-loaded nanoparticles are prepared by alginate ionotropic pre-gelation followed by chitosan polyelectrolyte complexation J Nanosci. Nanotechnol. 7 8 2833 2841
168. I. Aynié. Vectorisation d'oligonucleotides antisens par des nanoparticules d'alginate. Ph.D. Université Paris Sud-11. 01 February 1999.
169. I. Aynié C. Vauthier H. Chacun E. Fattal P. Couvreur 1999 Sponge-like alginate nanoparticles as a new system for the delivery of antisense oligonucleotides Antisense Nucleic Acid Drug Dev. 9 301 312
170. M. González Ferreiro L. Tillman G. Hardee R. Bodmeier 2002 Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers Int. J. Pharm. 239 1-2 47 59
171. P. Calvo C. Remuñan-Lopez J. L. Vila-Jato M. J. Alonso 1997 Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines Pharm. Res. 14 1431 1436
172. P. Calvo C. Remuñan-Lopez J. L. Vila-Jato M. J. Alonso 1997 Novel hydrophilic chitosan-polyethylene ocide nanoparticles as protein carriers J. Appl. Polym. Sci. 63 125 132
173. T. López-León E. L. Carvalho B. Seijo J. L. Ortega-Vinuesa D. Bastos-González 2005 Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior J. Colloid Interf. Sci. 283 2 344 351
174. R. Fernández-Urrusuno P. Calvo C. Remuñán- López J. L. Vila-Jato M. J. Alonso 1999 Enhancement of nasal absorption of insulin using chitosan nanoparticles Pharm. Res. 16 10 1576 1581
175. M. Cetin Y. Aktas I. Vural Y. Capan L.A. Dogan M. Duman T. Dalkara 2007 Preparation and in vitro evaluation of bFGF-loaded chitosan nanoparticles Drug. Deliv. 14 8 525 529
176. K. A. Janes P. Calvo M. J. Alonso 2001 Polysaccharide colloidal particles as delivery systems for macromolecules Adv. Drug Deliv. Rev. 47 1 83 97
177. H. Kastar H. O. Alpar 2006 Development and characterisation of chitosan nanoparticles for siRNA delivery J. Control. Release 115 2 216 225
178. T. H. Dung S. R. Lee S. D. Han S. J. Kim Y. M. Ju M. S. Kim H. Yoo 2007 Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment J. Nanosci. Nanotechnol. 7 11 3695 3699
179. C. Pegro D. Torres M. J. Alonso 2005 The potential of chitosan for the oral administration of peptides Expert. Opin. Drug. Deliv. 2 5 843 854
180. N. Csaba M. Garcia-Fuentes M. J. Alonso 2006 The performance of nanocarriers for transmucosal drug delivery Expert. Opin. Drug. Deliv. 3 4 463 478
181. S. M. Moghimi A. C. Hunter J. C. Murray 2005 Nanomedicine: current status and future prospects FASEB J. 19 311 330
182. A. Vonabourg C. Passirani P. Saulnier J. P. Benoit 2006 Parameters influencing the stealthiness of colloidal drug delivery systems Biomaterials 27 4356 4373
183. L. Nobs F. Buchegger R. Gurny E. Allemann 2004 Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting Eur. J. Pharm. Biopharm. 58 3 483 490
184. L. Nobs F. Buchegger R. Gurny E. Allemann 2004 Current methods for attaching targeting ligands to liposomes and nanoparticles J. Pharm. Sci. 93 8 1980 1992
185. B. Stella S. Arpicco M. T. Peracchia D. Desmaële J. Hoebeke M. Renoir J. D'Angelo L. Cattel P. Couvreur 2000 Design of folic acid-conjugated nanoparticles for drug targeting J. Pharm. Sci. 89 11 1452 1464
186. Y. De Kozak K. Andrieux H. Villarroya C. Klein B. Thillaye-Goldenberg M. C. Naud E. Garcia P. Couvreur 2004 Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis Eur. J. Immunol. 34 12 3702 3712
187. D. W. Barlet M. E. Davis 2007 Physicochemical and biological characterization of targeted nucleic acid-containing nanoparticles Bioconjug. Chem. 18 456 468
188. R. Gref P. Couvreur G. Barratt E. Mysiakine 2003 Surface-engineered nanoparticles for multiple ligand coupling Biomaterials 24 24 4529 4537
189. L. Illum L. O. Jacobsen R. H. Müller R. Mak S. S. Davis 1987 Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages Biomaterials 8 113 117
190. P. Calvo B. Gouritin H. Chacun D. Desmaële J. D'Angelo J. P. Noel G. Georgin E. Fattal J. P. Andreux P. Couvreur 2001 Long-circulating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery Pharm. Res. 18 8 1157 1166
191. J. Kreuter 2004 Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain J. Nanosci. Nanotechnol. 4 484 488
192. L. Grislain P. Couvreur V. Lenaerts M. Roland D. Deprez-Decampeneere P. Speiser 1983 Pharmacokinetics and distribution of a biodegradable drug-carrier Int. J. Pharm. 15 335 345
193. A. Béduneau P. Saulnier J. P. Benoit 2007 Active targeting of brain tumors using nanocarriers Biomaterials 28 33 4947 4967
194. I. Bertholon G. Ponchel D. Labarre P. Couvreur C. Vauthier 2006 Bioadhesive properties of poly(alkylcyanoacrylate) nanoparticles coated with polysaccharide J. Nanosci. Nanotechnol. 6 9-10 3102 3109
195. K. Albrecht A. Bernkop-Schnürch 2007 Thiomers: forms, functions and applications to nanomedicine Nanomedicine 2 1 41 50
196. K. Bouchemal 2008 New challenges for pharmaceutical formulations and drug delivery systems characterization using isothermal titration calorimetry Drug Discov. Today 13 21-22 960 972
197. M. E. Martinez-Barbosa L. Bouteiller S. Cammas-Marion V. Montembault L. Fontaine G. Ponchel 2008 Synthesis and ITC characterization of novel nanoparticles constituted by poly(gamma-benzyl L-glutamate)-beta-cyclodextrin J. Mol. Recognit. 21 3 169 178
198. Y. Aktaş M. Yemisci K. Andrieux R. N. Gürsoy M. J. Alonso E. Fernandez-Megia R. Novoa-Carballal E. Quiñoá R. Riguera M. F. Sargon H. H. Celik A. S. Demir A. A. Hincal T. Dalkara Y. Capan P. Couvreur 2005 Development and brain delivery of chitosan-PEG nanoparticles functionalized with the monoclonal antibody OX26 Bioconjug. Chem. 16 6 1503 1511
199. Bioalliance Pharma: Doxorubicin Transdrug®: Phase II/III http://www.bioalliancepharma.com Assessed 28 August 2008.
200. M. J. Hawkins P. Soon-Shiong N. Desai 2008 Protein nanoparticles as drug carriers in clinical medicine Adv. Drug. Deliv. Rev. 60 876 885
201. A. P. Colombo S. Briancon J. Lieto H. Fessi 2001 Project, design and use of a pilot plant for nanocapsule production Drug. Dev. Ind. Pharm. 27 10 1063 1072
202. S. A. Galindo-Rodriguez F. Puel S. Briançon E. Allémann E. Doelker H. Fessi 2005 Comparative scale-up of three methods for producing ibuprofen-loaded nanoparticles Eur. J. Pharm. Sci. 25 357 367
203. S. Briançon, H. Fessi, F. Lecomte, and J. Lieto. Study of an original production process of nanoparticles by precipitation, second ed. European Congress of Chemical Engineering, Montpellier, France (1999).
204. P. Tewa-Tagne S. Briançon H. Fessi 2007 Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterisation Eur. J. Pharm. Sci. 30 124 135
205. S. Watnasirichaikul T. Rades I. G. Tucker N. M. Davies 2002 In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsion J. Pharm. Pharmacol. 54 473 480
206. T. Govender S. Stolnik M. C. Garnett L. Illum S. S. Davis 1999 PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug J. Control. Release 57 171 185
207. S. K. Sahoo J. Panyam S. Prabha V. Labhasetwar 2002 Residual polyvinyl alcohol associated with poly (DL,-lactide-coglycolide) nanoparticles affects their physical properties and cellular uptake J. Control. Release 82 105 114
208. C. A. Nguyen E. Allemann G. Schwach E. Doelker R. Gurny 2003 Synthesis of a novel fluorescent poly (DL,-lactide) endcapped with 1-pyrenebutanol used for the preparation of nanoparticles Eur. J. Pharm. Sci. 20 217 222
209. I. Bravo-Osuna T. Schmitz A. Bernkop-Schnürch C. Vauthier G. Ponchel 2006 Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles Int. J. Pharm. 316 170 175
210. P. Beck D. Scherer J. Kreuter 1990 Separation of drug-loaded nanoparticles from free drug by gel filtration J. Microencapsul. 7 491 496
211. J. Zahka L. Mir 1977 Ultrafiltration of latex emulsions Chem. Eng. Prog. 73 53 55
212. G. Tishchenko K. Luetzow J. Schauer W. Albrecht M. Bleha 2001 Purification of polymer nanoparticles by diafiltration with polysulfone/ hydrophilic polymer blend membranes Sep. Purif. Technol. 22-23 403 415
213. G. Tishchenko R. Hilke W. Albrecht J. Schauer K. Luetzow Z. Pientka M. Bleha 2003 Ultrafiltration and microfiltration membranes in latex purification by diafiltration with suction Sep. Purif. Technol. 30 57 68
214. M. T. Peracchia C. Vauthier F. Puisieux P. Couvreur 1997 Development of sterically stabilized poly(isobutyl 2-cyanoacrylate) nanoparticles by chemical coupling of poly(ethylene glycol) J. Biomed. Mater. Res. 34 3 317 326
215. U. B. Kompella N. Bandi S. P. Ayalasomayajula 2001 Poly (lactic acid) nanoparticles for sustained release of budesonide Drug Deliv. Technol. 1 1 7
216. S. Prabha W. -Z. Zhou J. Panyam V. Labhasetwar 2002 Size dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles Int. J. Pharm. 244 105 115
217. S. Dreis F. Rothweiler M. Michaelis J. Cinatl Jr J. Kreuter K. Langer 2007 Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles Int. J. Pharm. 341 1-2 207 214
218. M. Hamoudeh A. Al Faraj E. Canet-Soulas F. Bessueille D. Léonard H. Fessi 2007 Elaboration of PLLA-based superparamagnetic nanoparticles: characterization, magnetic behaviour study and in vitro relaxivity evaluation Int. J. Pharm. 338 1-2 248 257
219. H. Pinto-Alphandary O. Balland P. Couvreur 1995 A new method to isolate poly(alkylcyanoacrylate) nanoparticle preparations J. Drug. Target. 3 167 169
220. E. Chiellini L. M. Orsini R. Solaro 2003 Polymeric nanoparticles based on polylactide and related co-polymers Macromol. Symp. 197 345 354
221. K. Bouchemal G. Ponchel S. Mazzaferro V.-H. Campos-Requena C. Gueutin G.-F. Palmieri C. Vauthier 2008 A new approach to determine loading efficiency of Leu-enkephalin in poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan J. Drug. Del. Sci. Tech. 22 12 2152 2162
222. G. Dalwadi H. A. Benson Y. Chen 2005 Comparison of diafiltration and tangential flow filtration for purification of nanoparticle suspensions Pharm. Res. 22 12 2152 2162
223. P. Harmant P. Aimar 1996 Materials, Interfaces and Electrochemical Phenomena coagulation of colloids retained by porous wall AIChE J. 42 3523
224. S. S. Madaeni A. G. Fane 1996 Microfiltration of very dilute colloidal mixtures J. Membr. Sci. 113 301 312
225. J. Rollot P. Couvreur L. Roblot-Treupel F. Puisieux 1986 Physicochemical and morphological characterization of polyisobutylcyanoacrylate nanocapsules J. Pharm. Sci. 75 361 364
226. V. Masson F. Maurin H. Fessi J. P. Devissaguet 1997 Influence of sterilization processes on poly(ε-caprolactone) nanospheres Biomaterials 18 327 335
227. P. Sommerfeld U. Schroeder B. A. Sabel 1998 Sterilization of unloaded polybutylcyanoacrylate nanoparticles Int. J. Pharm. 164 113 118
228. G. W. Bos A. Trullas-Jimeno W. Jiskoot D. J. A. Crommelin W. E. Hennink 2000 Sterilization of poly(dimethylamino) ethyl methacrylate-based gene transfer complexes Int. J. Pharm. 211 79 88
229. C. Boess K. W. Bögl 1996 Influence of radiation treatment on pharmaceuticals-a review: alkaloids, morphine derivatives and antibiotics Drug. Dev. Ind. Pharm. 22 6 495 529
230. M. B. Sintzel A. Merklia C. Tabatabay R. Gurny 1997 Influence of irradiation sterilization on polymers used as drug carriers : A review Drug. Dev. Ind. Pharm. 23 9 857 878
231. K. A. Athanasiou G. G. Niederauer C. M. Agrawal 1996 Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers Biomaterials 17 93 102
232. O. Maksimenko E. Pavlov E. Toushov A. Molin Y. Stukalov T. Prudskova V. Feldman J. Kreuter S. Gelperina 2008 Radiation sterilisation of doxorubicin bound to poly(butyl cyanoacrylate) nanoparticles Int. J. Pharm. 356 1-2 325 332
233. E. Memisoglu-Bilensoy A. A. Hincal 2006 Sterile, injectable cyclodextrin nanoparticles: Effects of gamma irradiation and autoclaving Int. J. Pharm. 311 203 208
234. B. Magenheim S. Benita 1991 Nanoparticle characterization: a comprehensive physicochemical approach STP Pharma. Sci. 1 221 241
235. I. Brigger L. Armand-Lefevre P. Chaminade M. Besnard Y. Rigaldie A. Largeteau A. Andremont L. Grislain G. Demazeau P. Couvreur 2003 The stenlying effect of high hydrostatic pressure on thermally and hydrolytically labile nanosized carriers Pharm Res. 20 4 674 683
236. F. Nemati, G. N. Cavé, and P. Couvreur. Lyophilization of substances with low water permeability by a modification of crystallized structures during Freezing. Proceedings of the 6th International Congress of Pharmaceutical Technology Assoc. Pharm. Galénique Ind., Châtenay Malabry, APGI, Paris-France. (3):487-493 (1992).
237. S. De Chasteigner H. Fessi G. Cavé J. P. Devissaguet F. Puisieux 1995 gastro-intestinal tolerance study of a freeze-dried oral dosage form of indomethacin-loaded nanocapsules S.T.P. Pharma Sci. 5 242 246
238. S. De Chasteigner G. Cavé H. Fessi J. P. Devissaguet F. Puisieux 1996 Freeze-drying of Itraconazole-loaded nanosphere suspensions : a feasibility study Drug. Dev. Res. 38 116 124
239. M. Auvillain G. Cavé H. Fessi J. P. Devissaguet 1989 Lyophilisation de vecteurs colloïdaux submicroniques STP Pharma. Sci 5 738 744
240. W. Abdelwahed G. Degobert S. Stainmesse H. Fessi 2006 Freeze-drying of nanoparticles: Formulation, process and storage considerations Adv. Drug. Deliv. Rev. 58 1688 1713
241. W. Abdelwahed G. Degobert H. Fessi 2006 Freeze-drying of nanocapsules: Impact of annealing on the drying process Int. J. Pharm. 324 74 82
242. P. Tewa-Tagne S. Briançon H. Fessi 2006 Spray-dried microparticles containing polymeric nanocapsules: Formulation aspects, liquid phase interactions and particles characteristics Int. J. Pharm. 325 63 74
243. A. M. Layre P. Couvreur J. Richard D. Requier N. E. Ghermani R. Gref 2006 Freeze-drying of composite core-shell nanoparticles Drug. Dev. Ind. Pharm. 32 7 839 846
244. F. De Jaeghere E. Allémann J. -C. Leroux W. Stevels J. Feijen E. Doelker R. Gurny 1999 Formulation and lyoprotection of poly (Lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake Pharm. Res. 16 859 866
245. M. Sameti G. Bohr M. N. V. Ravi Kumar C. Kneuer U. Bakowsky M. Nacken H. Schmidt C. -M. Lehr 2003 Stabilization by freeze-drying of cationically modified silica nanoparticles for gene delivery Int. J. Pharm. 266 51 60
246. W. Abdelwahed G. Degobert H. Fessi 2006 A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): Formulation and process optimization Int J Pharm. 309 178 188
247. B. Seijo E. Fattal L. Roblot-Treupel P. Couvreur 1990 Design of nanoparticles of less than 50 nm diameter: preparation, characterization and drug loading Int. J. Pharm. 62 1 7
248. T. W. Patapoff D. E. Overcashier 2002 The importance of freezing on lyophilization cycle development Biopharm 3 16 21
249. W. Abdelwahed G. Degobert H. Fessi 2006 Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage Eur. J. Pharm Biopharm. 63 87 94
250. J. Broadhead S. K. Edmond Rouan C. T. Rhodes 1992 The spray drying of pharmaceuticals Drug. Dev. Ind. Pharm. 18 1169 1206
251. M. Adler M. Unger G. Lee 2000 Surface composition of spray-dried particles of bovine serum albumin/trehalose/surfactant Pharm. Res. 17 863 870
252. C. R. Müller V. L. Bassani A. R. Pohlmann C. B. Michalowski P. R. Petrovick S. S. Guterres 2000 Preparation and characterization of spray-dried nanocapsules Drug. Dev. Ind. Pharm. 26 343 347
253. K. Master. Spray Drying Handbook. Longman Scientific and Technical, New York, 1991.
254. S. Bozdag K. Dillen J. Vandervoort A. Ludwig 2005 The effect of freeze drying with cryoprotectants and gamma-irradiation sterilization on the characteristics of ciprofloxacin HCl-loaded poly(D,L-lactideglycolide) nanoparticles J. Pharm. Pharmacol. 57 699 707
255. C. Vauthier B. Cabane D. Labarre 2008 How to concentrate nanoparticles and avoid aggregation ? Eur. J. Pharm. Biopharm. 69 466 475
256. F. Cournarie M. Chéron M. Besnard C. Vauthier 2004 Evidence for restrictive parameters in formulation of insulin-loaded nanocapsules Eur. J. Pharm. Biopharm. 57 2 171 179
257. D. V. Bazile C. Ropert P. Huve T. Verracchia M. Marlard A. Frydman M. Veillard G. Spenlehauer 1992 Body distribution of fully biodegradable [14C]-poly(lactic acid) nanoparticles coated with albumin after parenteral administration to rats Biomaterials 13 15 1093 1102
258. M. T. Peracchia E. Fattal D. Desmaële M. Besnard J. P. Noël J. M. Gomis M. Appel J. d'Angelo P. Couvreur 1999 Stealth PEGylated polycyanoacrylate nanoparticles for intravenous administration and splenic targeting J. Control. Release 60 1 121 128
259. H. Pinto-Alphandary M. Aboubakar D. Jaillard P. Couvreur C. Vauthier 2003 Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats Pharm. Res. 20 7 1071 1084
260. B. Weiss U. F. Schaefer J. Zapp A. Lamprecht A. Stallmach C. M. Lehr 2006 Nanoparticles made of fluorescence-labelled poly(L-lactide-co-glycolide): preparation, stability and biocompatibility J. Nanosci. Nanotechnol. 6 9-10 3048 3056
261. M. A. Pereira V. C. Mosqueira J. M. Vilela M. S. Andrade G. A. Ramaldes V. N. Cardose 2008 PLA-PEG nanocapsules radiolabelled with 99 m Technitium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy Eur. J. Pharm. Sci. 33 42 51
262. M. Simeonova T. Ivanova Z. Raikov H. Konstantinov 1994 Tissue distribution of polybutylcyanoacrylate nanoparticles loaded with spin-labelled nitrosourea in Lewis lung carcinoma-bearing mice Acta Physiol. Pharmacol. Bulg. 20 3-4 77 82
263. M. Tobio A. Sanchez A. Vila I. I. Soriano C. Evora J. L. Vila-Jato M. J. Alonso 2000 The role of PEG on the stability in digestive fluids and in vivo fate of PEG-PLA nanoparticles following oral administration Colloids Surf. B. Biointerfaces 18 3-4 315 323
264. P. Prabu, A. A Chaudhari, N. Dharmaraj, M. S. Khil, S. Y. Park, and H. Y. Kim. Preparation, characterization, in-vitro drug release and cellular uptake of poly(caprolactone) grafted dextran copolymeric nanoparticles loaded with anticancer drug. J. Biomed. Mater. Res: A. (2008). [doi: 10.1002/jbm.a.32163 ]
265. G. Sun A. Hagooly J. Xu A. M. Nyström Z. Li R. Rossin D. A. Moore K. L. Wooley M. L. Welch 2008 Facile, efficient approach to accomplish tunable chemistries and variable biodistributions for shell cross-linked nanoparticles Biomacromolecules 9 7 1997 2006
266. 3H]-labeled poly(ε-caprolactone) J. Labelled Compd Rad. 43 271 281
267. 3H] and fluorescence-labeled poly(lactide) J. Labelled Compd Rad. 44 10 677 687
268. S. Ponsart J. Coudane B. Saulnier J. L. Morgat M. Vert 2001 Biodegradation of [(3)H]poly(ε-caprolactone) in the presence of active sludge extracts Biomacromolecules 2 2 373 377
269. I. Bertholon H. Hommel D. Labarre C. Vauthier 2006 Properties of Polysaccharides Grafted on Nanoparticles Investigated by EPR Langmuir 22 5485 5490
270. C. Chauvierre C. Vauthier D. Labarre H. Hommel 2004 Evaluation of the surface properties of dextran coated poly(isobutylcyanocrylate) nanoparticles by Spin-labelling coupled with electron resonance spectroscopy Colloid Polym. Sci. 282 1016 1025